ADAM17 and atherosclerosis: The TACE expression is increased in atherosclerosis (Canault et al., 2006) and in the left ventricle after Ang-II infusion (Patel et al., 2014) and that ADAM17 polymorphism is associated with cardiovascular mortality (Morange et al., 2008; Takayanagi et al., 2016).